MannKind Corp
MNKD
#5739
Rank
NZ$2.26 B
Marketcap
NZ$7.04
Share price
-2.53%
Change (1 day)
-21.29%
Change (1 year)

Earnings for MannKind Corp (MNKD)

Earnings in 2026 (TTM): -NZ$84.88 Million

According to MannKind Corp's latest financial reports the company's current earnings are NZ$0.39 Billion. In 2025 the company made an earning of NZ$2.57 Million a decrease over its 2024 earnings that were of NZ$55.78 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MannKind Corp from 2004 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$84.88 Million-3399.78%
2025 NZ$2.57 M-95.39%
2024 NZ$55.78 M-394.09%
2023 -NZ$18.97 Million-88.13%
2022 -NZ$0.16 Billion8%
2021 -NZ$0.15 Billion40.84%
2020 -NZ$0.11 Billion10.7%
2019 -NZ$94.88 Million-40.16%
2018 -NZ$0.16 Billion-26.04%
2017 -NZ$0.22 Billion-193.33%
2016 NZ$0.22 B-134.11%
2015 -NZ$0.68 Billion85.72%
2014 -NZ$0.37 Billion3.6%
2013 -NZ$0.36 Billion12.79%
2012 -NZ$0.32 Billion5.58%
2011 -NZ$0.3 Billion-5.72%
2010 -NZ$0.32 Billion-22.51%
2009 -NZ$0.41 Billion-27.37%
2008 -NZ$0.56 Billion3.36%
2007 -NZ$0.54 Billion27.18%
2006 -NZ$0.43 Billion101.63%
2005 -NZ$0.21 Billion50.46%
2004 -NZ$0.14 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$12.73 B-14,421.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
NZ$42.01 B-47,339.69%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
NZ$63.55 B-71,562.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.28 B-13,917.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
NZ$1.06 B-1,298.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-NZ$0.28 Billion 214.70%๐Ÿ‡บ๐Ÿ‡ธ USA